XAR ETF Soars 41.7% But Still Undervalued: Why $242 Is in Sight

XAR ETF Soars 41.7% But Still Undervalued: Why $242 Is in Sight

Equal-Weight Edge, Defense Spending, and Strategic Holdings Make NYSEARCA:XAR a Strong Buy at $208.93 | That's TradingNEWS

TradingNEWS Archive 7/3/2025 10:23:55 PM
Stocks Markets RKLB BA CW AVAV

Defense Acceleration, Budget Windfalls, and Strategic Tilt Drive NYSEARCA:XAR ETF Higher

XAR Commands Aerospace & Defense Surge Amid Budget Expansion

The NYSEARCA:XAR ETF has emerged as the most dynamic play in the aerospace and defense sector, up over 41.7% in the past year and currently trading near $208.93, just 1.25% below its all-time high of $211.56. This performance outpaces competitors like ITA (+37.2%) and PPA (+32.01%) thanks to XAR's equal-weighted methodology, minimizing mega-cap bias and amplifying upside across its diversified 40-stock portfolio.

Institutional Demand and Structural Tailwinds Fuel Growth Narrative

With $3.5 billion AUM and net inflows exceeding $375 million YTD, XAR has become a key instrument for institutions seeking sector exposure to the U.S. military-industrial complex. NATO’s 5% GDP defense target by 2035, Germany and Poland’s escalated spending (Poland now at 4.1% of GDP), and the U.S.'s proposed $1 trillion national security budget under Trump mark a clear directional trend toward elevated military outlays. XAR’s component companies — like AeroVironment (AVAV), Rocket Lab (RKLB), and Kratos (KTOS) — directly benefit from this expansion, especially as they secure battlefield, drone, and satellite contracts.

Diversification Edge and Tactical Positioning Among Peers

Compared to ITA’s 32.3% and PPA’s 26.8% exposure to the top four defense primes (Boeing, Northrop, RTX, Lockheed), XAR's 14.2% exposure ensures no single name dominates, safeguarding against single-stock risk. Its top five holdings — each below 4.5% weight — include Rocket Lab (4.3%), AeroVironment (4.3%), Huntington Ingalls (3.6%), Kratos (3.5%), and General Dynamics (3.5%). The 0.35% expense ratio undercuts PPA (0.57%) while offering far better recent return dynamics.

Valuation and Forward Price Implication

XAR trades at a P/E of 38x, in line with its 3-year average and below its peak of 44x earnings. With defense revenues accelerating and multiple expansion likely, a re-rating back to 44x implies 16% upside, suggesting a tactical price target near $242. This is backed by Warren Buffett's doctrine: it's preferable to buy a great business at a fair price than the reverse — and XAR now represents a high-conviction bet on defense innovation and resilience.

Geopolitical Catalysts Ignite Price Floors and Upside Risk

Recent U.S.-Israel operations in Iran reinforced the centrality of U.S. defense contractors. Bunker-busting munitions (Boeing's GBU-57), stealth bombers (Northrop’s B-2), and RTX’s cruise missiles were deployed in conflict zones — each tied to XAR holdings. These strike tools are irreplaceable in defense planning. Their rising use confirms the sector’s strategic importance, with no clear path to spending reversals. As supply chains re-shore and weapon systems modernize, XAR’s relevance only compounds.

Fundamentals Aligned with Macro and Fiscal Trends

The ETF’s dividend yield of 0.53%, while modest, complements the growth story and highlights reinvestment efficiency. Quarterly rebalancing ensures responsiveness to shifting fundamentals. The commercial aerospace recovery also adds a dual engine to growth, with Boeing (4.0% weight) poised to regain delivery strength amid global fleet replenishment. If geopolitical crises endure — or escalate — XAR's upward re-pricing remains justified by earnings momentum.

Buy/Sell/Hold Verdict: BUY — Undervalued with 16% Upside to $242

NYSEARCA:XAR combines broad sector exposure, tactical weighting, superior 12-month return, and a cost-effective structure. Its valuation is fair, not stretched, with plenty of catalysts remaining: a trillion-dollar U.S. budget, NATO expansion, active theater deployment, and satellite-drone convergence. Any dip toward $195–200 is an accumulation opportunity. Even without a peace-time breakout, XAR is positioned for outperformance.

Current Price: $208.93
Upside Target: $242.00
Risk Zone: Below $186.00
Bias: STRONG BUY — Tactical and Strategic Sector Alpha in One ETF

That's TradingNEWS